MR

Michael Rome

Managing Director & Head of Therapeutics Investing at Foresite Capital

Los Angeles Metropolitan Area

Overview

Work Experience

FC

Foresite Capital

  • Managing Director

    2016 - Current

RayThera

  • Board Member

    2023

CO

CG Oncology

  • Board Observer

    2023

AT

Avenzo Therapeutics

  • Board Member

    2022

KB

Kinnate Biopharma Inc.

  • Board Member

    2018

A

Alumis

  • Board Member and Observer

    2021

RT

Remix Therapeutics

  • Board Member

    2020

XinThera Inc.

  • Board Member

    2021 - 2023

AI

Affinivax Inc.

  • Board Observer

    2021 - 2022

TP

Turning Point Therapeutics

  • Board Observer

    2018 - 2019

    Co-led series D financing

Education

Investments

Alumis

Series A

Total Funding: $330M

Remix Therapeutics

Series A

Total Funding: $210M

CG Oncology

Series F

Total Funding: $110M

XinThera

Series B

Total Funding: $50M

Relevant Websites